Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neurotrophin receptor p75NTR mediates Huntington’s disease–associated synaptic and memory dysfunction
Verónica Brito, Albert Giralt, Lilian Enriquez-Barreto, Mar Puigdellívol, Nuria Suelves, Alfonsa Zamora-Moratalla, Jesús J. Ballesteros, Eduardo D. Martín, Nuria Dominguez-Iturza, Miguel Morales, Jordi Alberch, Sílvia Ginés
Verónica Brito, Albert Giralt, Lilian Enriquez-Barreto, Mar Puigdellívol, Nuria Suelves, Alfonsa Zamora-Moratalla, Jesús J. Ballesteros, Eduardo D. Martín, Nuria Dominguez-Iturza, Miguel Morales, Jordi Alberch, Sílvia Ginés
View: Text | PDF
Research Article Neuroscience

Neurotrophin receptor p75NTR mediates Huntington’s disease–associated synaptic and memory dysfunction

  • Text
  • PDF
Abstract

Learning and memory deficits are early clinical manifestations of Huntington’s disease (HD). These cognitive impairments have been mainly associated with frontostriatal HD pathology; however, compelling evidence provided by several HD murine models suggests that the hippocampus may contribute to synaptic deficits and memory dysfunction in HD. The neurotrophin receptor p75NTR negatively regulates spine density, which is associated with learning and memory; therefore, we explored whether disturbed p75NTR function in the hippocampus could contribute to synaptic dysfunction and memory deficits in HD. Here, we determined that levels of p75NTR are markedly increased in the hippocampus of 2 distinct mouse models of HD and in HD patients. Normalization of p75NTR levels in HD mutant mice heterozygous for p75NTR prevented memory and synaptic plasticity deficits and ameliorated dendritic spine abnormalities, likely through normalization of the activity of the GTPase RhoA. Moreover, viral-mediated overexpression of p75NTR in the hippocampus of WT mice reproduced HD learning and memory deficits, while knockdown of p75NTR in the hippocampus of HD mice prevented cognitive decline. Together, these findings provide evidence of hippocampus-associated memory deficits in HD and demonstrate that p75NTR mediates synaptic, learning, and memory dysfunction in HD.

Authors

Verónica Brito, Albert Giralt, Lilian Enriquez-Barreto, Mar Puigdellívol, Nuria Suelves, Alfonsa Zamora-Moratalla, Jesús J. Ballesteros, Eduardo D. Martín, Nuria Dominguez-Iturza, Miguel Morales, Jordi Alberch, Sílvia Ginés

×

Figure 5

Normalization of p75NTR levels in mutant KI mice prevents functional and structural synaptic plasticity deficits.

Options: View larger image (or click on image) Download as PowerPoint
Normalization of p75NTR levels in mutant KI mice prevents functional and...
(A) Time course of fEPSP potentiation during HSF-induced LTP in WT (n = 3), p75+/– (n = 4), KI (n = 9), and KI:p75+/– (n = 8) mice at 6 months of age. **P < 0.01 compared with WT mice. (B and C) Representative basal (B) and apical dendrites (C) of CA1 pyramidal neurons from WT, p75+/–, KI, and KI:p75+/– mice at 8 months of age. Right: Quantitative analysis showing dendritic spine density per micrometer of dendritic length. Mutant KI mice exhibit a significant reduction in dendritic spines that was significantly ameliorated in double-mutant mice. One-way ANOVA with Tukey post hoc comparisons was performed (63–83 dendrites; n = 4–5 animals per genotype); ***P < 0.001 compared with WT mice; §§P < 0.01, §§§P < 0.001 compared with KI mice. (D) Percentage of each morphological type of dendritic spine (see Methods and Supplemental Figure 4 for classification criteria) from WT, p75+/–, KI, and KI:p75+/– basal dendrites at 8 months of age. One-way ANOVA with Tukey post hoc comparisons was performed (480 spines from 100 dendrites from 4 animals per genotype were analyzed); ***P < 0.001 compared with WT mice. (E and F) Spine neck length distribution was examined by plotting of the cumulative frequency of neck length of all examined spines and comparison of distributions using the Kolmogorov-Smirnov test. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with WT mice. §§P < 0.01 compared with KI mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts